Phthalate esters in human milk: concentration variations over a 6-month postpartum time

Jiping Zhu1, Susan P Phillips, Yong-Lai Feng

  • 1Chemistry Research Division, Health Canada AL: 0800C, EHC (Building 8), Tunney's Pasture, Ottawa, Ontario, Canada K1A 0L2. Jiping_Zhu@hc-sc.gc.ca

The present study investigated the levels of phthalate esters in a total of 86 human milk samples collected among 21 breast-feeding mothers over a 6-month postpartum time. Di(2-ethylhexyl) phthalate (DEHP) was the predominant ester with the arithmetic mean value of 222 ng g(-1) (range: 156-398 ng g(-1), 95% confidence limit), followed by dibutyl phthalate (DBP), 0.87 (range: 0.62-1.2) ng g(-1). Diethyl phthalate (DEP), with a mean of 0.31 ng g(-1), was detected in only a small number of samples. Weak correlations between lipid content and levels of phthalate esters were observed. The levels of phthalate esters in human milk fluctuated over the 6-month period; this may indicate a need for multiple sample collection, to calculate average concentrations over the feeding period. Multiple sample collection would provide a better estimate of the exposure of breast-fed infants to phthalate in human milk. For infants relying on breast-feeding, the mean daily intake over the first 6-month period considering a 7 kg infant consuming 750 g of milk was estimated at 167 microg d(-1) for DEHP and less than 1 microg d(-1) for DBP and DEP. While the nutritional and social benefits of breast-feeding are well established, the potential transfer of phthalate esters from mothers to breast-fed infants should also be recognized.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...